Literature DB >> 2566915

Early dopamine agonist therapy in Parkinson's disease.

U K Rinne1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2566915     DOI： 10.1002/mds.870040511

Source DB:  PubMed          Journal:  Mov Disord        ISSN： 0885-3185            Impact factor:   10.338


× No keyword cloud information.
  2 in total

Review 1.  Pharmacodynamic and pharmacokinetic features of cabergoline. Rationale for use in Parkinson's disease.

Authors:  R G Fariello
Journal:  Drugs       Date:  1998       Impact factor: 9.546

2.  Transdermal administration of the dopamine agonist N-0437 and seven ester prodrugs: comparison with oral administration in the 6-OHDA turning model.

Authors:  I den Daas; P G Tepper; H Rollema; A S Horn
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-12       Impact factor: 3.000
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.